scPharmaceuticals Inc (NASDAQ: SCPH) is -7.34% lower on its value in year-to-date trading and has touched a low of $3.08 and a high of $6.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SCPH stock was last observed hovering at around $3.42 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $3.28, the stock is -4.60% and -7.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing -4.09% at the moment leaves the stock -23.73% off its SMA200. SCPH registered -43.15% loss for a year compared to 6-month loss of -26.95%. The firm has a 50-day simple moving average (SMA 50) of $3.54 and a 200-day simple moving average (SMA200) of $4.300425.
The stock witnessed a 2.50% gain in the last 1 month and extending the period to 3 months gives it a -25.62%, and is -3.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.06% over the week and 5.70% over the month.
scPharmaceuticals Inc (SCPH) has around 136 employees, a market worth around $164.13M and $30.28M in sales. Profit margin for the company is -264.60%. Distance from 52-week low is 6.67% and -49.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-96.55%).
with sales reaching $12.07M over the same period.The EPS is expected to shrink by -27.01% this year, but quarterly earnings will post 166.67% year-over-year. Quarterly sales are estimated to grow 98.01% in year-over-year returns.
scPharmaceuticals Inc (SCPH) Top Institutional Holders
124.0 institutions hold shares in scPharmaceuticals Inc (SCPH), with institutional investors hold 91.50% of the company’s shares. The shares outstanding are 50.04M, and float is at 34.54M with Short Float at 18.71%. Institutions hold 81.73% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 5.56 million shares valued at $24.18 million. The investor’s holdings represent 14.2727% of the SCPH Shares outstanding. As of 2024-06-30, the second largest holder is RUBRIC CAPITAL MANAGEMENT LP with 3.52 million shares valued at $15.33 million to account for 9.0496 of the shares outstanding. The other top investors are AIGH CAPITAL MANAGEMENT LLC which holds 3.5 million shares representing 8.9966% and valued at over $15.24 million, while KING LUTHER CAPITAL MANAGEMENT CORP holds 5.6612 of the shares totaling 2.21 million with a market value of $9.59 million.
scPharmaceuticals Inc (SCPH) Insider Activity
The most recent transaction is an insider purchase by ORBIMED ADVISORS LLC, the company’s 10% Owner. SEC filings show that ORBIMED ADVISORS LLC bought 500,000 shares of the company’s common stock on Aug 13 ’24 at a price of $4.00 per share for a total of $2.0 million. Following the purchase, the insider now owns 5.81 million shares.
